XML 35 R26.htm IDEA: XBRL DOCUMENT
v3.22.2

Revenue (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2022
Revenue from Contract with Customer [Abstract] |
Schedule of Total Revenue by Category and by U.S versus Rest of World | The following table presents detail regarding the composition of the Company’s total revenue by type and by U.S. versus rest of world (“RoW”):
| Three months ended June 30,
| 2022 |  |  | 2021
(in millions) | U.S. |  | RoW |  | Total |  |  | U.S. |  | RoW |  | Total
Molecular diagnostic revenues: |  |  |  |  |  |  |  |  |  |  |  |
Hereditary Cancer | $ | 69.8 |  |  | $ | 9.6 |  |  | $ | 79.4 |  |  |  | $ | 73.8 |  |  | $ | 12.2 |  |  | $ | 86.0 |
Tumor Profiling | 21.5 |  |  | 12.0 |  |  | 33.5 |  |  |  | 18.2 |  |  | 12.1 |  |  | 30.3 |
Prenatal | 33.1 |  |  | 0.2 |  |  | 33.3 |  |  |  | 29.2 |  |  | 0.2 |  |  | 29.4 |
Pharmacogenomics | 33.1 |  |  | — |  |  | 33.1 |  |  |  | 22.6 |  |  | — |  |  | 22.6 |
Autoimmune | — |  |  | — |  |  | — |  |  |  | 10.2 |  |  | — |  |  | 10.2 |
Other | — |  |  | — |  |  | — |  |  |  | 0.2 |  |  | — |  |  | 0.2 |
Total molecular diagnostic revenue | 157.5 |  |  | 21.8 |  |  | 179.3 |  |  |  | 154.2 |  |  | 24.5 |  |  | 178.7 |
Pharmaceutical and clinical services revenue | — |  |  | — |  |  | — |  |  |  | 10.7 |  |  | — |  |  | 10.7 |
Total revenue | $ | 157.5 |  |  | $ | 21.8 |  |  | $ | 179.3 |  |  |  | $ | 164.9 |  |  | $ | 24.5 |  |  | $ | 189.4 |
| Six months ended June 30,
| 2022 |  |  | 2021
(in millions) | U.S. |  | RoW |  | Total |  |  | U.S. |  | RoW |  | Total
Molecular diagnostic revenues: |  |  |  |  |  |  |  |  |  |  |  |
Hereditary Cancer | $ | 130.5 |  |  | $ | 19.8 |  |  | $ | 150.3 |  |  |  | $ | 138.9 |  |  | $ | 23.2 |  |  | $ | 162.1 |
Tumor Profiling | 41.2 |  |  | 24.8 |  |  | 66.0 |  |  |  | 42.1 |  |  | 19.4 |  |  | 61.5 |
Prenatal | 64.8 |  |  | 0.4 |  |  | 65.2 |  |  |  | 52.8 |  |  | 0.3 |  |  | 53.1 |
Pharmacogenomics | 62.4 |  |  | — |  |  | 62.4 |  |  |  | 40.2 |  |  | — |  |  | 40.2 |
Autoimmune | 0.3 |  |  | — |  |  | 0.3 |  |  |  | 20.9 |  |  | — |  |  | 20.9 |
Other | — |  |  | — |  |  | — |  |  |  | 0.5 |  |  | — |  |  | 0.5 |
Total molecular diagnostic revenue | 299.2 |  |  | 45.0 |  |  | 344.2 |  |  |  | 295.4 |  |  | 42.9 |  |  | 338.3 |
Pharmaceutical and clinical services revenue | — |  |  | — |  |  | — |  |  |  | 24.2 |  |  | — |  |  | 24.2 |
Total revenue | $ | 299.2 |  |  | $ | 45.0 |  |  | $ | 344.2 |  |  |  | $ | 319.6 |  |  | $ | 42.9 |  |  | $ | 362.5 |
Reconciliation of Deferred Revenue Balances | A reconciliation of the beginning and ending balances of deferred revenue is shown in the table below:
| Six months ended June 30,
(in millions) | 2022 |  |  | 2021
Deferred revenue - beginning balance | $ | 5.2 |  |  |  | $ | 32.7 |
Revenue recognized | (5.2) |  |  |  | (15.5) |
Prepayments | 0.3 |  |  |  | 6.3 |
Held for sale reclassification | — |  |  |  | (0.9) |
Deferred revenue - ending balance | $ | 0.3 |  |  |  | $ | 22.6 |

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration